![R. Alan B. Ezekowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
R. Alan B. Ezekowitz
Directeur/Membre du Conseil chez
ORGANON & CO.
Fortune : 4 M $ au 30/06/2026
Profil
Dr. R.
Alan B. Ezekowitz is an Independent Director at Organon & Co., an Independent Director at Fulcrum Therapeutics, Inc., a Member at American Society of Clinical Investigation and a Venture Partner at CHP Management, Inc. He is on the Board of Directors at Septerna, Inc., Organon & Co., Fulcrum Therapeutics, Inc. and Codman Co., Inc. Dr. Ezekowitz was previously employed as an Advisory Partner by Third Rock Ventures LLC, a Non-Executive Director by Oxagen Ltd., a Principal by Alan Ezekowitz LLC, a Chief Executive Officer & Director by Abide Therapeutics, Inc., a Senior Vice President by Merck Research Laboratories Massachusetts LLC, a Co-Founder by Azanta Danmark AS, a Director & Chief-Pediatric Services by Partners HealthCare System, Inc., an Associate Professor by Harvard Medical School, a Chairman-Scientific Advisory Board by Anika Therapeutics, Inc., a Director-Scientific Advisory Board by Entomed SA, and a Chairman by The Massachusetts General Hospital.
He also served on the board at Atopix Therapeutics Ltd. and The Children's Hospital Corp.
He received his graduate degree from the University of Cape Town and a doctorate degree from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SEPTERNA, INC. 0,26% | 26/06/2026 | 117 420 ( 0,26% ) | 4 M $ | 30/06/2026 |
| 30/06/2026 | 10 927 ( 0,02% ) | 39 993 $ | 30/06/2026 | |
ORGANON & CO. -.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de R. Alan B. Ezekowitz
| Sociétés | Poste | Début |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2016 |
| ORGANON & CO. | Directeur/Membre du Conseil | 02/06/2021 |
| SEPTERNA, INC. | Directeur/Membre du Conseil | 01/12/2022 |
American Society of Clinical Investigation | Corporate Officer/Principal | - |
CHP Management, Inc.
 CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Private Equity Investor | 01/01/2011 |
Codman Co., Inc. | Directeur/Membre du Conseil | 20/08/2009 |
Anciens postes connus de R. Alan B. Ezekowitz
| Sociétés | Poste | Fin |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Consultant / Advisor | 01/12/2022 |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Fondateur | 01/05/2019 |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Directeur/Membre du Conseil | 22/08/2017 |
| ░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de R. Alan B. Ezekowitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
The Children's Hospital Corp.
 The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Health Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entomed SA
 Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Health Technology |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Commercial Services |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
The Massachusetts General Hospital
 The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
American Society of Clinical Investigation | |
Codman Co., Inc. | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel class of medicines to treat atopic dermatitis and severe asthma | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Organon & Co.
 Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Alan Ezekowitz LLC |
Choisissez Zonebourse 
